Literature DB >> 16170693

Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells.

Shirui Mao1, Oliver Germershaus, Dagmar Fischer, Thomas Linn, Robert Schnepf, Thomas Kissel.   

Abstract

PURPOSE: The effect of chitosan and polyethylene glycol (PEG)ylated trimethyl chitosan copolymer structure on the uptake and transport of insulin nanocomplexes was evaluated and transport mechanisms were investigated.
METHODS: Insulin nanocomplexes were prepared from chitosan and its copolymers by self-assembly. Complex uptake in Caco-2 cells was quantified by measuring the cell-associated fluorescence and cellular localization was visualized by confocal laser scanning microscopy (CLSM) using tetra-methyl-rhodamine isothiocyanate-labeled insulin. The transport of selected insulin complexes through Caco-2 monolayers was then investigated and compared with in vivo uptake by nasal epithelium in diabetic rats.
RESULTS: All complexes were 200-400 nm in diameter, positively charged, and displayed an insulin loading efficiency of approximately 90%. In vitro release of insulin from the complexes was dependent on the medium pH. Insulin uptake was enhanced by nanocomplex formation, and was dependent on incubation time, temperature, and concentration. Complex uptake in Caco-2 cells was inhibited by 25.2 +/- 1.3%, 13.0 +/- 1.0%, and 16.6 +/- 0.7% in the presence of cytochalasin D, sodium azide, and 2,4-dinitrophenol, respectively. The uptake mechanism was assumed to be adsorptive endocytosis. Additionally, cell uptake efficiency was shown to be influenced by a combination of polymer molecular weight, viscosity, and positive charge density. However, none of the nanocomplexes displayed improved transport properties when compared to insulin transport data after 2 h incubation with Caco-2 monolayers. This result was further confirmed with animal experiments.
CONCLUSIONS: Small, stable insulin nanocomplexes were formed using PEGylated trimethyl chitosan copolymers, which significantly enhanced the uptake of insulin in Caco-2 cells by adsorptive endocytosis. However, nanocomplexation did not seem to enhance transcellular insulin transport across cell monolayers, which is in line with animal data in rats. This implies that PEGylated trimethyl chitosan complexes with insulin need further optimization and the Caco-2 cell line is a predictable in vitro cell culture model for drug absorption.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170693     DOI: 10.1007/s11095-005-8175-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Evaluation of nano- and microparticle uptake by the gastrointestinal tract.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

Review 2.  Chitosan as a novel nasal delivery system for vaccines.

Authors:  L Illum; I Jabbal-Gill; M Hinchcliffe; A N Fisher; S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-09-23       Impact factor: 15.470

3.  Role of calcium in tight junction formation between epithelial cells.

Authors:  L Gonzalez-Mariscal; R G Contreras; J J Bolívar; A Ponce; B Chávez De Ramirez; M Cereijido
Journal:  Am J Physiol       Date:  1990-12

4.  Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells.

Authors:  N G Schipper; K M Vårum; P Artursson
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

5.  Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments.

Authors:  Thomas Merdan; Klaus Kunath; Dagmar Fischer; Jindrich Kopecek; Thomas Kissel
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

6.  Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).

Authors:  P Artursson; T Lindmark; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

Review 7.  Polysaccharide colloidal particles as delivery systems for macromolecules.

Authors:  K A Janes; P Calvo; M J Alonso
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

8.  The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.

Authors:  M P Desai; V Labhasetwar; E Walter; R J Levy; G L Amidon
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

9.  The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1).

Authors:  Giulia Ranaldi; Iolanda Marigliano; Isabella Vespignani; Giuditta Perozzi; Yula Sambuy
Journal:  J Nutr Biochem       Date:  2002-03       Impact factor: 6.048

10.  Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells.

Authors:  M M Zegers; K J Zaal; S C van IJzendoorn; K Klappe; D Hoekstra
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

View more
  15 in total

Review 1.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

2.  Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.

Authors:  Reza Mahjub; Farid Abedin Dorkoosh; Mohsen Amini; Mohammad Reza Khoshayand; Morteza Rafiee-Tehrani
Journal:  AAPS PharmSciTech       Date:  2011-10-27       Impact factor: 3.246

3.  Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells--towards oral insulin.

Authors:  Colin Thompson; Woei Ping Cheng; Pramod Gadad; Karen Skene; Mhairi Smith; Gillian Smith; Alastair McKinnon; Rachel Knott
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

4.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

Authors:  Huan Meng; Min Xue; Tian Xia; Zhaoxia Ji; Derrick Y Tarn; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2011-04-27       Impact factor: 15.881

5.  Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Authors:  B Sarmento; A Ribeiro; F Veiga; P Sampaio; R Neufeld; D Ferreira
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

6.  PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release.

Authors:  X G Zhang; D Y Teng; Z M Wu; X Wang; Z Wang; D M Yu; C X Li
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

7.  Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration.

Authors:  Niels Hagenaars; Enrico Mastrobattista; Rolf J Verheul; Imke Mooren; Harrie L Glansbeek; Jacco G M Heldens; Han van den Bosch; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-02-18       Impact factor: 4.200

Review 8.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

Review 9.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

10.  Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin.

Authors:  Zhen-Hai Zhang; Yin-Long Zhang; Jian-Ping Zhou; Hui-Xia Lv
Journal:  Int J Nanomedicine       Date:  2012-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.